The Global Digital Pathology Systems Market is Projected to Reach US$759.6 Million by 2024

Growing Need to Enhance Workflow Efficiencies, Reduce Costs and Ensure Reliable Outcomes to Drive the Global Digital Pathology Systems Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Digital Pathology Systems market. The global Digital Pathology Systems market is projected to reach US$759.6 million by 2024, driven by the growing need for efficient, faster and cost-effective methods for accurate pathological assessment. The need to reduce the ever growing workload of pathologists is also driving adoption of digital pathology systems.

Digital pathology, a dynamic, image-driven model, helps pathologists, histology personnel and laboratory managers in acquiring, managing and interpreting the pathology-related information from a digitized glass slide. Digital pathology has emerged as a revolutionary pathology model that not only addresses issues associated with traditional pathology processes but also provides pathologists with a new IT tool that can address their ever-growing workload issues. In the diagnostics space, digital pathology systems continue gain traction in medical microscopy, blood analysis, biopsy and dissection among others in the diagnosis of physiological disorders, and organic and infectious diseases.

The global market for digital pathology systems is being driven by the technology’s ability to enhance operational efficiency, provide novel treatment methods, reduce lab expenses and more importantly improve overall patient care is fueling their adoption. The growing need for real time access to accurate pathology outcomes constitutes a major driving force for the digital pathology market. Increasing prevalence of various chronic diseases, such as cancer and cardiac diseases, due to an aging population and changing lifestyles are enhancing the need for faster and more reliable testing and diagnosis systems, thus fueling growth in the digital pathology systems market. Also driving growth are factors such as rising awareness about diagnostic technologies and steadily growing disposable incomes of people across developed and developing economies, which will foster demand for digital pathology systems.

Increasing private and government expenditure on healthcare reforms currently underway in various countries across the world is also driving focus onto digital pathology systems. One of the major factors influencing adoption of digital pathology systems is the current focus on implementing IT in all areas of healthcare industry. The sustained advancements in the field of information technology, which is enabling better connectivity of systems across the healthcare network, also augur well for the market. In particular, digital pathology market is expected to benefit from the growing use of cloud-based technology for storing digital slides and providing secure access to pathologists.

As stated by the new market research report on Digital Pathology Systems, the United States represents the largest market worldwide supported by rising awareness about benefits of using digital pathology techniques, favorable reimbursement policies in place, growing prevalence of cancer and other life-threatening diseases, and the escalating use of companion diagnostics. The growth is also being driven by the rising work burden of pathologists and the increased willingness of clinics and hospitals to adopt digital pathology procedures. Asia-Pacific is forecast to register the fastest CAGR of 14.2% over the analysis period. The region benefits from sustained increase in spending on healthcare IT infrastructure facilities, as well as increased demand for better decision making tools and technologies from pathologists.

Major players in the market include 3DHISTECH Ltd., Apollo Enterprise Imaging Corp., Carl Zeiss AG, Corista LLC, Definiens AG, Hamamatsu Photonics K.K., Huron Digital Pathology Inc., Leica Biosystems Nussloch GmbH, MikroScan Technologies Inc., Olympus Corporation, Philips Healthcare, Pixcelldata Ltd., Ventana Medical Systems Inc., and VMscope GmbH, among others.

The research report titled “Digital Pathology Systems: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections for all major geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific, Latin America and Rest of World.

To connect with us, visit our LinkedIn page.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.